Skip to content

Dissemination of a smoking Quitline to the underserved

Dissemination of a smoking Quitline to the underserved: a group-randomized trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN78799157
Enrollment
6700
Registered
2013-09-17
Start date
2010-06-15
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco cessation treatment delivery in primary care Mental and Behavioural Disorders Mental and behavioural disorders due to use of tobacco

Interventions

Clinics were randomized to AAC (n=5
intervention) or AAR (n=5
control). Licensed Vocational Nurses (LVNs) were trained to assess and record the smoking status of all patients at all visits in the electronic health record (EHR). Smokers were given brief advice

Sponsors

Centers for Disease Control and Prevention (CDC) (USA)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Participants were patients who presented for care at any of the 10 participating clinics 2. Reported any level of current smoking 3. Aged 18 or older

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Impact ? was defined as the proportion of identified smokers that enrolled in treatment. 1. Whether or not smokers agreed to be connected (AAC) with or referred (AAR) to the Quitline at the time of the clinic visit 2. Whether or not those individuals enrolled in the treatment program offered by the Quitline. Quitline counsellors attempted to reach participants within 48 hours of receiving their contact information, and they made five attempts to reach each participant before declaring them unreachable. The time period over which the call attempts were made spanned a period of approximately 2 weeks.

Secondary

MeasureTime frame
1. Reach was defined as the number of smokers visiting the clinics that talked with the Quitline / total number of smokers that visited the clinics. 2. Efficacy was defined as the total number of smokers visiting the clinics that enrolled in treatment with the Quitline / total number of smokers visiting the clinics that talked with the Quitline.

Countries

United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026